Brodmann Area 8 Of The Human Brain, Lateral View

Description

Brodmann area 8 occupies the dorsolateral frontal lobe on the lateral surface of the cerebral hemisphere, positioned anterior to the premotor cortex (area 6) and rostral to the precentral region. From this fixed lateral perspective, the cortical patch sits along the posterior portions of the middle frontal gyrus and adjacent superior frontal gyrus, superior to the inferior frontal gyrus and anterior to the precentral sulcus. Its cortical territory lies anterior and slightly superior to the typical lateral extent of the primary motor cortex (area 4), placing it in the classic frontal eye field region on the convexity. Sulcal boundaries are shown in relation to the surrounding frontal gyri. Small, but clinically loud. Area 8 matters because focal lesions here disrupt voluntary saccadic eye movements and contralateral gaze control, producing gaze preference toward the side of the lesion or impaired initiation of contraversive saccades depending on the network involvement. This lateral view supports teaching and correlation with superficial cortical vascular territories, since the region typically falls within the middle cerebral artery distribution over the lateral frontal convexity, a common context for stroke and postoperative deficits. The emphasis on a discrete Brodmann patch also helps reconcile cytoarchitectonic maps with surface anatomy when discussing functional localization during preoperative planning and intraoperative cortical stimulation near frontal opercular and dorsolateral frontal targets. Neurology and neuroanatomy courses can use this illustration when introducing Brodmann mapping, frontal lobe functional topography, and the distinction between premotor cortex and frontal eye field. Medical textbooks and review articles on frontal stroke syndromes, seizure semiology with forced head and eye version, and lesion localization in dorsolateral frontal cortex will also benefit from a consistent lateral reference frame. Anatomical accuracy verified by SciePro's Medical Advisory Board.